DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Conte P, Frassoldati A, Bisagni G. et al
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study.
Ann Oncol 2018;
29 (12) 2328-2333
We do not assume any responsibility for the contents of the web pages of other providers.